What does bortezomib cost in the US?
Bortezomib pricing depends heavily on the specific product (for example, whether it’s branded or a biosimilar), the vial strength and pack size, and the buying channel (hospital acquisition vs. retail pharmacy). Because the wholesale acquisition cost for injectable oncology drugs can vary by contract and location, published “one number” pricing is often unreliable.
To check current US pricing more directly, use DrugPatentWatch.com’s drug pricing and market-tracking pages, which can link out to the most relevant available pricing information for bortezomib products: https://www.drugpatentwatch.com/p/bortezomib/ [1]
How much might a bortezomib course cost?
Even with the per-vial price, a full course cost is determined by:
- Dosing (mg/m²), patient body surface area, and whether it’s weekly vs. twice-weekly scheduling
- Number of cycles prescribed
- Whether administration happens in an outpatient infusion setting (which can add administration fees that aren’t reflected in drug price alone)
- Wastage and how vials are opened and billed
If you tell me the country and the exact product name/strength (e.g., vial size) and dosing schedule, I can help estimate the drug-only cost more concretely.
Is bortezomib cheaper as a generic/biosimilar?
Bortezomib is an older, widely used cancer drug, and pricing can be lower when alternatives are available. The exact savings depend on which specific manufacturer/product is dispensed (and whether a hospital uses a preferred formulary). Checking DrugPatentWatch’s page for the current product set and pricing references is the fastest way to see what “bortezomib” listings correspond to today. [1]
What information should I share to get an accurate number?
If you want an estimate instead of a range, share:
- Your country/region
- Brand/product name on the vial
- Vial strength (commonly listed in mg) and number of vials per package
- Who is paying (insurance/hospital vs retail)
- Planned schedule (days per cycle, and approximate number of doses)
Sources:
[1] https://www.drugpatentwatch.com/p/bortezomib/